25
Participants
Start Date
April 28, 2023
Primary Completion Date
October 31, 2024
Study Completion Date
October 31, 2024
Efavaleukin alfa
Subcutaneous (SC) injection
Placebo
SC injection
MIND Klinika Kft, Budapest
Clinexpert Kft, Budapest
Clinica Independencia, Munro
Diagnostic-Consultative Center Convex EOOD, Sofia
Herlev Hospital, Herlev
Intesto BE, Bern
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged
Wonju Severance Christian Hospital, Wonju-si, Gangwon-do
Mersin Universitesi Tip Fakultesi Hastanesi, Mersin
Indian Health Service Health Research, Kissimmee
Kocaeli Universitesi Tip Fakultesi Hastanesi, Kocaeli
Clinica de Investigacion en Reumatologia y Obesidad SC, Guadalajra
University of Kansas Medical Center, Kansas City
Universitaetsklinikum Ulm, Ulm
Santa Maria Gastroenterology Medical Group, Santa Maria
Centro de Investigaciones Medicas Mar del Plata, Mar del Plata
Cer Instituto Medico, Quilmes
Tsujinaka Hospital Kashiwanoha, Kashiwa-shi
Nagasaki University Hospital, Nagasaki
Ome Medical Center, Ome-shi
NZOZ Twoje Zdrowie EL Spzoo, Elblag
Centrum Medyczne Melita Medical, Wroclaw-Krzyki
Clinica Medicum, Bucharest
Memorial Healthcare International SRL, Bucharest
Spitalul Clinic Colentina, Bucharest
Lead Sponsor
Amgen
INDUSTRY